The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
2688 results found
High-quality national clinical trials and cohort studies aiming to improve the health and wellbeing of all Australians will receive over $77 million in funding under the National Health and Medical Research Council’s (NHMRC) Clinical Trials and Cohort Studies grant scheme.
Professor Alta Schutte, SHARP Professor and Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine at the University of New South Wales and The George Institute for Global Health, focuses on implementing effective scalable interventions for global blood pressure control. Appointed Co-Chair of the National Hypertension Taskforce in 2022, she was recognised in 2023 as the Leading Researcher in Vascular Medicine by The Australian. Notably, she received the 2022 Harriet Dustan Award from the American Heart Association and the 2023 Peter Sleight Excellence award from the World Hypertension League. Her impactful work extends to improving cardiovascular health in Australia and beyond.
Professor Sharon Lewin is the Director of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. Her research has focused on strategies to achieve an HIV cure, enhancing clinical outcomes for people living with HIV and hepatitis B and the identification of novel treatments for COVID-19. She is internationally known for her development of laboratory models to study HIV latency and for leading innovative early phase clinical trials aimed at reversing HIV latency. Professor Lewin has received Melburnian of the Year (2014), the Peter Wills Medal from Research Australia (2015), Officer of the Order of Australia (2019), and Medal for Outstanding Female Researcher by the Australian Academy of Health and Medical Sciences (2022).
Dr Jiayan Liao is a dedicated researcher specialising in the field of nanotechnology, nanomedicine, biomedical engineering, and their applications in medical diagnostics. Dr Liao’s research focuses on developing innovative diagnostic tools for early cancer detection, leveraging photonics, fluorescent nanoprobes, and artificial intelligence for precise detection of single-molecule biomarkers in diseases and cancers. Dr Liao is contributing to the advancement of diagnostic methodologies and technologies, aiming for non-invasive, early detection methods to improve patient outcomes.
Professor Anthony Don is Professor of Medical Biochemistry in the School of Medical Sciences at the University of Sydney. His team develops and applies advanced mass spectrometry methods to investigate how alterations to brain lipid metabolism with ageing lead to dementia, develop neuroprotective therapeutics, and discover new biomarkers for demyelinating diseases. His research has uncovered deficits in lipid metabolism that destabilise myelin in the course of normal ageing and early in Alzheimer’s disease pathogenesis. He also developed and coordinates the popular masters-level unit of study, Advances in Disease Diagnosis and Treatment.
Dr Romain Ragonnet is a Senior Research Fellow in the Epidemiological Modelling Unit at Monash University. Dr Ragonnet specialises in the mathematical modelling of tuberculosis (TB) and COVID-19, and his notable contributions include the first-ever quantification of TB mortality and self-recovery rates. Dr Ragonnet has advised various governments of lower-middle-income countries in the Asia-Pacific region to assist the local control of TB and COVID-19. He also initiated and led multiple cross-disciplinary collaborations, creating a strong network of world-leading experts that spans mathematics, medical ethics, biostatistics, economics, and clinical trials.
Dr Sean Humphrey leads the Functional Phosphoproteomics Laboratory at the Murdoch Children’s Research Institute. Dr Humphrey’s research uses cutting-edge mass spectrometers to create detailed molecular maps that capture how cells communicate and process information by regulating proteins. Dr Humphrey completed his PhD at the University of New South Wales before moving to Germany to undertake post-doctoral training at the Max Planck Institute of Biochemistry in Munich. Dr Humphrey’s research pinpoints key molecular signals that are dysregulated in human disease, uncovering a myriad of new targets for future therapies.
With the announcement of 12 collaborative health and medical research projects today, Australian researchers are set to improve the translation and delivery of collaborative research outcomes into healthcare policy and practice.
The National Health and Medical Research Council (NHMRC) continues to invest in our nation’s health and medical research sector, with over $411 million awarded to 229 outstanding researchers to investigate Australia’s greatest health challenges.
Dr Johanna Birrell is a general physician and advanced trainee in public health medicine. Dr Birrell has trained in both Australia and New Zealand and has a particular interest in rural health, Indigenous health, and health services research. Dr Birrell is completing her postdoctoral studies at the University of Sydney with concurrent clinical work. Her research explores geographic variation in kidney failure epidemiology and access to care across Australia and New Zealand. Dr Birrell has received awards including the Royal Australasian College of Physicians 2023 Aotearoa Trainee Research Award for Excellence in the Field of Adult Medicine and the Gerry Murphy Prize in 2022.
Six expert teams will share in over $5 million in funding to stimulate research into ensuring the quality and safety of telehealth, and its potential to achieve positive health outcomes under the National Health and Medical Research Council’s (NHMRC) Targeted Call for Research (TCR): Ensuring the quality and safety of telehealth 2023.
The Budget 2024–25, delivered on 14 May 2024, confirms the Australian Government’s ongoing commitment to supporting health and medical research and its translation into new health treatments and technologies to improve the health of the Australian community.
The National Health and Medical Research Council (NHMRC) has released Grant Opportunity Guidelines for a Targeted Call for Research (TCR) into 2024.
The 27th biannual report.
The 40th biannual report
The 34th biannual report
The 32nd biannual report.
The 30th biannual report.